HIGHLIGHTS
- who: Shirin Nkongolo and colleagues from the General Hospital University Health Network, Toronto, Ontario, Canada have published the research: Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T_cells Toronto, in the Journal: (JOURNAL)
- what: In this study, data are shown from 9 patients who, at the time of enrollment, had active CHB with elevated alanine aminotransferase (ALT) levels, mean ALT 8.9 u00d7 upper limit of normal (ULN) (range: 1.1-21.8 u00d7 ULN), and had started to receive 25 mg/d TAF (Supplemental Figure 1A; supplemental . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.